Summary

Sleep Apnea Devices Market, Industry Trends and Global Forecasts, till 2035 - Distribution by Product Type (Sleep Apnea Medical Devices and Drug Therapies), Type of Diagnostic Device (Polysomnography Devices and Home Sleep Apnea Testing Devices), Type of Therapeutic Device (Positive Airway Pressure Devices, Oral Devices and Implantable Devices), Type of Positive Airway Pressure Device (CPAP Machine, BiPAP, APAP and Other Devices), Route of Administration (Oral Therapies and Subcutaneous Therapies) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World)
Report Link: https://www.rootsanalysis.com/reports/sleep-apnea-devices-market.html
The sleep apnea devices market is valued at USD 13.5 billion in 2023 growing at a CAGR of 4.61% during the forecast period 2023-2035.
Sleep apnea, also known as sleep apnea, is a serious sleep disorder characterized by repeated interruptions in breathing during sleep. These interruptions can last for several minutes. Sleep apnea is broadly classified into three types: obstructive sleep apnea, central sleep apnea, and complex sleep apnea. Among these, obstructive sleep apnea and central sleep apnea are the most common types, sharing similar symptoms such as loud snoring, morning headaches, excessive daytime sleepiness, and dry mouth.
Sleep apnea is often undiagnosed and can affect individuals of all age groups. Obesity and excess weight are identified as the leading causes of sleep apnea in adults, while modern lifestyle-related factors like smoking, alcohol consumption, lack of physical activity, and psychological stress also contribute to its increasing prevalence. Medical professionals are increasingly focused on developing effective, safe, and versatile diagnosis and treatment options for sleep apnea. Currently, various therapeutic devices are used for its treatment. Given the rising burden of sleep apnea and ongoing research efforts to develop advanced medical devices for obstructive sleep apnea, the market for sleep apnea devices is expected to witness steady growth in the forecast period.


Key Market Segments
Product Type
Sleep Apnea Medical Devices
Sleep Apnea Drug Therapies
Type of Diagnostic Device
Polysomnography Devices
Home Sleep Apnea Testing Devices
Type of Therapeutic Device
Positive Airway Pressure Devices
Oral Devices
Implantable Devices
Type of Positive Airway Pressure Device
CPAP Machine
BiPAP Machines
APAP Machines
Other Machines
Route of Administration
Oral Therapies
Subcutaneous Therapies
Key Geographical Regions
North America
Europe
Asia-Pacific
Rest of the World

Research Coverage:
The report studies the sleep apnea devices market based on product type, type of diagnostic device, type of therapeutic device, type of positive airway pressure device, route of administration and key geographical regions.
The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.
The report forecasts the revenue of market segments with respect to four major regions
A comprehensive overview of sleep apnea is presented, encompassing details on its various types and impact on health. Additionally, the discussion includes an overview of the devices utilized for both diagnosis and treatment of sleep apnea. Furthermore, information is provided on the ongoing research into drug therapies for sleep apnea.
An extensive evaluation of the overall market landscape of diagnostic devices for detecting sleep apnea is conducted, considering various pertinent parameters. These parameters include the type of device, physiological parameters monitored, type of sleep apnea diagnosed, device connectivity, target patient segment, end user and pricing. Additionally, the chapter includes information on various device developers, accompanied by an analysis based on multiple parameters such as the year of establishment, company size, and location of headquarters.
An in-depth evaluation of the overall market landscape for therapeutic devices used in the treatment of sleep apnea is conducted, taking into consideration several key parameters. These parameters include the type of sleep apnea treated, therapeutic principles employed, type of device, type of mask, type of treatment, device connectivity, storage options, target patient segment, end users, and pricing. Additionally, the chapter provides information on various device developers, accompanied by an analysis based on multiple parameters such as the year of establishment, company size, location of headquarters, and identification of the most active players in terms of the number of products developed.
A comprehensive examination of the current market landscape for drug therapies targeting sleep apnea treatment is provided, considering several key parameters. These parameters include the phase of development, type of therapy, route of administration, number of doses, and target patient segment. Additionally, the chapter presents information on various therapy developers, accompanied by an analysis based on multiple parameters such as the year of establishment, company size, and location of headquarters.
Detailed profiles of prominent companies engaged in the sleep apnea market are presented, selected based on the strength of their product portfolios. Each profile provides a concise overview of the company, including details on the year of establishment, number of employees, location of headquarters, and leadership team. Furthermore, the profiles include information on the company's product portfolio, recent developments, and an informed future outlook.
An insightful analysis of completed and ongoing clinical trials related to sleep apnea is conducted, considering various relevant parameters such as trial registration year, trial phase, trial status, type of sponsor/collaborator, study design, trial focus area, number of patients enrolled, and the most active players based on the number of clinical trials conducted. Additionally, the analysis includes geographical considerations.
An examination of partnerships within the sleep apnea market since 2017 is provided, covering various types of agreements including acquisitions, product/technology integration agreements, distribution agreements, service alliances, commercialization agreements, research agreements, and other relevant agreements.
A detailed analysis of funding and investments in sleep apnea companies since 2019 is conducted, considering various parameters such as year of investment, amount invested, type of funding, investment focus area, leading players, key investors, and geographical analysis.
An in-depth analysis of patents filed or granted related to sleep apnea since 2019 is presented, considering parameters such as the type of patent, patent publication year, patent jurisdiction, cooperative patent classification (CPC) symbols, type of applicant, leading industry players, leading non-industry players, and leading individual assignees. Additionally, the chapter includes a detailed patent benchmarking analysis and a valuation analysis highlighting leading patents based on the number of citations.
The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
Key Benefits of Buying this Report
The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
The report provides stakeholders with a pulse on the sleep apnea devices market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.
Key Market Companies
Acurable
Advanced Brain Monitoring
Airway Management
Apnimed
Bayer
Belun Technology
BRAEBON Medical
Cadwell
Desitin Pharma
Drive DeVilbiss Healthcare
Eli Lilly and Company
Hunan Ventmed Medical Technology
Incannex Healthcare
Löwenstein Medical
Nihon Kohden
Nox Medical
Oventus Medical
Philips
React Health
ResMed
SciSparc
Sibelmed
Somnetics International inc
SomnoMed
Sunrise
Topson Medical
Vyaire Medical
Wellue
Whole You
ZOLL Itamar

ページTOPに戻る

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5 Research Methodology
1.6. Frequently Asked Questions
1.7. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Future Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Introduction to Sleep Apnea
5.3. Type of Sleep Apnea
5.3.1. Obstructive Sleep Apnea
5.3.2. Central Sleep Apnea
5.3.3. Complex Sleep Apnea
5.4. The Impact of Sleep Apnea on Health
5.5. Diagnosis of Sleep Apnea
5.6. Treatment of Sleep Apnea
5.6.1. Therapeutic Devices for Sleep Apnea
5.6.2. Drug Therapies for Sleep Apnea
5.7. Concluding Remarks
6. SLEEP APNEA DIAGNOSTIC DEVICES: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Sleep Apnea Diagnostic Devices: Overall Market Landscape
6.2.1. Analysis by Type of Device
6.2.2. Analysis by Physiological Parameters Monitored
6.2.3. Analysis by Type of Sleep Apnea Diagnosed
6.2.4. Analysis by Device Connectivity
6.2.5. Analysis by Target Patient Segment
6.2.6. Analysis by End User
6.2.7. Analysis by Price
6.3. Sleep Apnea Diagnostic Devices: Developer Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Analysis by Company Size and Location of Headquarters
7. SLEEP APNEA THERAPEUTIC DEVICES: MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Sleep Apnea Therapeutic Devices: Overall Market Landscape
7.2.1. Analysis by Type of Sleep Apnea Treated
7.2.2. Analysis by Therapeutic Principle
7.2.3. Analysis by Type of Device
7.2.4. Analysis by Type of Mask
7.2.5. Analysis by Type of Treatment
7.2.6. Analysis by Device Connectivity
7.2.7. Analysis by Type of Storage Offered
7.2.8. Analysis by Target Patient Segment
7.2.9. Analysis by End User
7.2.10. Analysis by Price
7.3. Sleep Apnea Therapeutic Devices: Developer Landscape
7.3.1. Analysis by Year of Establishment
7.3.2. Analysis by Company Size
7.3.3. Analysis by Location of Headquarters
7.3.4. Analysis by Company Size and Location of Headquarters
7.3.5. Most Active Players: Analysis by Number of Products
8. SLEEP APNEA DRUG THERAPIES: MARKET OVERVIEW
8.1. Chapter Overview
8.2. Sleep Apnea Drug Therapies: Overall Market Landscape
8.2.1. Analysis by Phase of Development
8.2.2. Analysis by Type of Drug Therapy
8.2.3. Analysis by Route of Administration
8.2.4. Analysis by Number of Doses
8.2.5. Analysis by Target Patient Segment
8.3. Sleep Apnea: Developer Landscape (Industry Players)
8.3.1. Analysis by Year of Establishment
8.3.2. Analysis by Company Size
8.3.3. Analysis by Location of Headquarters
8.3.4. Analysis by Company Size and Location of Headquarters
9. COMPANY PROFILES: SLEEP APNEA DIAGNOSTIC DEVICE DEVELOPERS
9.1. Chapter Overview
9.2. Cadwell
9.2.1. Company Overview
9.2.2. Device Portfolio
9.2.3. Recent Developments and Future Outlook
9.3. Itamar Medical
9.3.1. Company Overview
9.3.2. Device Portfolio
9.3.3. Recent Developments and Future Outlook
9.4. Nox Medical
9.4.1. Company Overview
9.4.2. Device Portfolio
9.4.3. Recent Developments and Future Outlook
9.5. Other Leading Diagnostic Device Developers
9.5.1. Acurable
9.5.2. Advanced Brain Monitoring
9.5.3. Belun Technology
9.5.4. Braebon Medical
9.5.5. Nihon Kohden
9.5.6. Sibelmed
9.5.7. Sunrise
9.5.8. Vyaire Medical
9.5.9. Wellue
10. COMPANY PROFILES: SLEEP APNEA THERAPEUTIC DEVICE DEVELOPERS
10.1. Chapter Overview
10.2. Löwenstein Medical
10.2.1. Company Overview
10.2.2. Device Portfolio
10.2.3. Recent Developments and Future Outlook
10.3. ResMed
10.3.1. Company Overview
10.3.2. Device Portfolio
10.3.3. Recent Developments and Future Outlook
10.4. SomnoMed
10.4.1. Company Overview
10.4.2. Device Portfolio
10.4.3. Recent Developments and Future Outlook
10.5. Other Leading Therapeutic Device Developers
10.5.1. Airway Management
10.5.2. Drive DeVilbiss Healthcare
10.5.3. Hunan VentMed Medical Technology
10.5.4. Oventus
10.5.5. Philips
10.5.6. React Health
10.5.7. Somnetics International
10.5.8. Topson Medical
10.5.9. Whole You
11. COMPANY PROFILES: SLEEP APNEA DRUG THERAPY DEVELOPERS
11.1. Chapter Overview
11.2. Apnimed
11.2.1. Company Overview
11.2.2. Drug Therapy Portfolio
11.2.3. Recent Developments and Future Outlook
11.3. Desitin Pharma
11.3.1. Company Overview
11.3.2. Drug Therapy Portfolio
11.3.3. Recent Developments and Future Outlook
11.4. Incannex Healthcare
11.4.1. Company Overview
11.4.2. Drug Therapy Portfolio
11.4.3. Recent Developments and Future Outlook
11.5. Other Leading Drug Therapy Developers
11.5.1. Bayer
11.5.2. Eli Lilly and Company
11.5.3. SciSparc
12. CLINICAL TRIAL ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Sleep Apnea: Clinical Trial Analysis
12.3.1. Analysis by Trial Registration Year
12.3.2. Analysis by Trial Phase
12.3.3. Analysis by Trial Status
12.3.4. Analysis by Trial Registration Year and Trial Status
12.3.5. Analysis by Type of Sponsor / Collaborator
12.3.6. Analysis by Study Design
12.3.6.1. Analysis by Type of Patient Allocation Model Used
12.3.6.2. Analysis by Type of Intervention
12.3.6.3. Analysis by Type of Trial Masking Adopted
12.3.6.4. Analysis by Trial Purpose
12.3.7. Analysis by Trial Focus Area
12.3.8. Analysis of Patients Enrolled by Trial Registration Year
12.3.9. Analysis of Patients Enrolled by Trial Phase
12.3.10. Most Active Industry Players: Analysis by Number of Clinical Trials
12.3.11. Most Active Non-Industry Players: Analysis by Number of Clinical Trials
12.3.12. Analysis of Clinical Trials by Geography
12.3.12.1. Analysis of Clinical Trials by Geography and Trial Status
12.3.12.2. Analysis of Patients Enrolled by Trial Status and Geography
13. PARTNERSHIPS AND COLLABORATIONS
13.1. Chapter Overview
13.2. Partnership Models
13.3. Sleep Apnea Therapies and Devices: Partnerships and Collaborations
13.3.1. Analysis by Year of Partnership
13.3.2. Analysis by Type of Partnership
13.3.3. Analysis by Year and Type of Partnership
13.3.4. Analysis by Type of Partner
13.3.5. Most Active Players: Analysis by Number of Partnerships
13.3.6. Analysis by Geography
13.3.6.1. Local and International Deals
13.3.6.2. Intercontinental and Intracontinental Deals
14. FUNDING AND INVESTMENT ANALYSIS
14.1. Chapter Overview
14.2. Types of Funding
14.3. Sleep Apnea: Funding and Investment Analysis
14.3.1. Analysis by Year of Investment
14.3.2. Analysis of Amount Invested by Year
14.3.3. Analysis by Type of Funding
14.3.4. Analysis of Amount Invested by Type of Funding
14.3.5. Analysis of Amount Invested by Year and Type of Funding
14.3.6. Analysis by Investment Focus Area
14.3.7. Most Active Players: Analysis by Number of Instances
14.3.8. Most Active Players: Analysis by Amount Raised
14.3.9. Analysis by Type of Investor
14.3.10. Leading Investors: Analysis by Number of Funding Instances
14.3.11. Analysis by Geography
14.3.11.1. Analysis of Instances by Geography
14.3.11.2. Analysis of Amount Invested by Geography
15. PATENT ANALYSIS
15.1. Chapter Overview
15.2. Scope and Methodology
15.3. Sleep Apnea: Patent Analysis
15.3.1. Analysis by Type of Patent
15.3.2. Analysis by Patent Publication Year
15.3.3. Analysis by Type of Patent and Patent Publication Year
15.3.4. Analysis by Patent Jurisdiction
15.3.5. Analysis by CPC Symbols
15.3.6. Analysis by Type of Applicant
15.3.7. Leading Industry Players: Analysis by Number of Patents
15.3.8. Leading Non-Industry Players: Analysis by Number of Patents
15.3.9. Leading Individual Assignees: Analysis by Number of Patents
15.4. Sleep Apnea: Patent Benchmark Analysis
15.4.1. Analysis by Patent Characteristics
15.5. Patent Valuation Analysis
16. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
16.1. Chapter Overview
16.2. Market Drivers
16.3. Market Restraints
16.4. Market Opportunities
16.5. Market Challenges
16.6. Conclusion
17. GLOBAL SLEEP APNEA MARKET
17.1. Chapter Overview
17.2. Assumptions and Methodology
17.3. Global Sleep Apnea Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.3.1. Scenario Analysis
17.4. Key Market Segmentations
18. GLOBAL SLEEP APNEA MARKET BY TYPE OF PRODUCT
18.1. Chapter Overview
18.2. Assumptions and Methodology
18.3. Global Sleep Apnea Market: Distribution by Type of Product, 2018, 2023 and 2035
18.3.1. Sleep Apnea Medical Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.3.2. Drug Therapies: Forecasted Estimates (2025-2035)
18.4. Data Triangulation and Validation
19. GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET
19.1. Chapter Overview
19.2. Assumptions and Methodology
19.3. Scenario 1: Global Sleep Apnea Diagnostic Devices Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.3.1. Scenario Analysis
20. SLEEP APNEA DIAGNOSTIC DEVICES MARKET: DISTRIBUTION BY TYPE OF DIAGNOSTIC DEVICE
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Sleep Apnea Diagnostic Devices Market: Distribution by Type of Diagnostic Device, 2018, 2023 and 2035
20.3.1. Polysomnography Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.2. Home Sleep Apnea Testing Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4. Data Triangulation and Validation
21. SLEEP APNEA DIAGNOSTIC DEVICES MARKET: DISTRIBUTION BY KEY GEOGRAPHICAL REGIONS
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Sleep Apnea Diagnostic Devices Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035
21.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.3.4. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.4. Data Triangulation and Validation
22. GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET
22.1. Chapter Overview
22.2. Assumptions and Methodology
22.3. Global Sleep Apnea Therapeutic Devices Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
22.3.1. Scenario Analysis
23. SLEEP APNEA THERAPEUTIC DEVICES MARKET: DISTRIBUTION BY TYPE OF THERAPEUTIC DEVICE
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Sleep Apnea Therapeutic Devices Market: Distribution by Type of Therapeutic Device, 2018, 2023 and 2035
23.3.1. PAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
23.3.2. Oral Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
23.3.3. Implanted Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
23.4. Data Triangulation and Validation
24. SLEEP APNEA THERAPEUTIC DEVICES MARKET: DISTRIBUTION BY TYPE OF PAP DEVICE
24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Sleep Apnea Therapeutic Devices Market: Distribution by Type of PAP Device, 2018, 2023 and 2035
24.3.1. CPAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
24.3.2. BiPAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
24.3.3. APAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
24.3.4. Other Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
24.4. Data Triangulation and Validation
25. SLEEP APNEA THERAPEUTIC DEVICES MARKET: DISTRIBUTION BY KEY GEOGRAPHICAL REGIONS
25.1. Chapter Overview
25.2. Key Assumptions and Methodology
25.3. Sleep Apnea Therapeutic Devices Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035
25.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
25.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
25.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
25.3.4. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
25.4. Data Triangulation and Validation
26. GLOBAL SLEEP APNEA DRUG THERAPIES MARKET
26.1. Chapter Overview
26.2. Assumptions and Methodology
26.3. Global Sleep Apnea Drug Therapies Market: Forecasted Estimates (2025-2035)
26.3.1. Scenario Analysis
26.4. Sleep Apnea Drug Therapies Market: Drug Therapy-Wise Sales Forecast, 2025-2035
27. SLEEP APNEA DRUG THERAPIES MARKET: DISTRIBUTION BY ROUTE OF ADMINISTRATION
27.1. Chapter Overview
27.2. Assumptions and Methodology
27.3. Sleep Apnea Drug Therapies Market: Distribution by Route of Administration, 2025 and 2035
27.3.1. Oral Drug Therapies Market: Forecasted Estimates (2026-2035)
27.3.2. Subcutaneous Drug Therapies Market: Forecasted Estimates (2025-2035)
28. SLEEP APNEA DRUG THERAPIES MARKET: DISTRIBUTION BY KEY GEOGRAPHICAL REGIONS
28.1. Chapter Overview
28.2. Key Assumptions and Methodology
28.3 Sleep Apnea Drug Therapies Market: Distribution by Key Geographical Regions, 2025 and 2035
28.3.1. North America: Forecasted Estimates (2025-2035)
28.3.1.1. US: Forecasted Estimates (2025-2035)
28.3.1.2. Mexico: Forecasted Estimates (2025-2035)
28.3.2. Europe: Forecasted Estimates (2026-2035)
28.3.2.1. Belgium: Forecasted Estimates (2027-2035)
28.3.2.2. Germany: Forecasted Estimates (2026-2035)
28.3.3. Asia-Pacific: Forecasted Estimates (2026-2035)
28.3.3.1. Australia: Forecasted Estimates (2026-2035)
28.3.3.2. China: Forecasted Estimates (2026-2035)
28.3.3.3. Japan: Forecasted Estimates (2026-2035)
28.3.3.4. Taiwan: Forecasted Estimates (2026-2035)
28.3.4. Rest of the World: Forecasted Estimates (2026-2035)
28.3.4.1. Brazil: Forecasted Estimates (2026-2035)
29. CONCLUSION
30. APPENDIX 1: TABULATED DATA
31. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

ページTOPに戻る

List of Tables/Graphs

Table 6.1 Sleep Apnea Diagnostic Devices: Information on Developer and Type of Device
Table 6.2 Sleep Apnea Diagnostic Devices: Information on Physiological Parameter Monitored
Table 6.3 Sleep Apnea Diagnostic Devices: Information on Type of Sleep Apnea Diagnosed
Table 6.4 Sleep Apnea Diagnostic Devices: Information on Device Connectivity
Table 6.5 Sleep Apnea Diagnostic Devices: Information on Target Patient Segment
Table 6.6 Sleep Apnea Diagnostic Devices: Information on End User and Price
Table 6.7 Sleep Apnea Diagnostic Devices: List of Developers
Table 7.1 Sleep Apnea Therapeutic Devices: Information on Developer and Type of Sleep Apnea Treated
Table 7.2 Sleep Apnea Therapeutic Devices: Information on Therapeutic Principle
Table 7.3 Sleep Apnea Therapeutic Devices: Information on Type of Device and Type of Mask
Table 7.4 Sleep Apnea Therapeutic Devices: Information on Type of Treatment
Table 7.5 Sleep Apnea Therapeutic Devices: Information on Device Connectivity and Type of Storage Offered
Table 7.6 Sleep Apnea Therapeutic Devices: Information on Target Patient Segment
Table 7.7 Sleep Apnea Therapeutic Devices: Information on End User and Price
Table 8.1 Sleep Apnea Drug Therapies: Information on Developer, Type of Player, Phase of Development and Type of Sleep Apnea Treated
Table 8.2 Sleep Apnea Drug Therapies: Information on Type of Drug Therapy, Route of Administration, Number of Doses and Target Patient Segment
Table 8.3 Sleep Apnea Drug Therapies: List of Drug Therapy Developers (Industry Players)
Table 9.1 Sleep Apnea Diagnostic Device Developers: List of Companies (Detailed Profiles)
Table 9.2 Sleep Apnea Diagnostic Device Developers: List of Companies (Tabulated Profiles)
Table 9.3 Cadwell: Company Overview
Table 9.4 Cadwell: Product Portfolio
Table 9.5 Cadwell: Recent Developments and Future Outlook
Table 9.6 Itamar Medical: Company Overview
Table 9.7 Itamar Medical: Product Portfolio
Table 9.8 Itamar Medical: Recent Developments and Future Outlook
Table 9.9 Nox Medical: Company Overview
Table 9.10 Nox Medical: Product Portfolio
Table 9.11 Nox Medical: Recent Developments and Future Outlook
Table 9.12 Acurable: Company Overview
Table 9.13 Acurable: Product Portfolio
Table 9.14 Advanced Brain Monitoring: Company Overview
Table 9.15 Advanced Brain Monitoring: Product Portfolio
Table 9.16 Belun Technology: Company Overview
Table 9.17 Belun Technology: Product Portfolio
Table 9.18 Braebon Medical: Company Overview
Table 9.19 Braebon Medical: Product Portfolio
Table 9.19 Nihon Kohden: Company Overview
Table 9.20 Nihon Kohden: Product Portfolio
Table 9.21 Sibelmed: Company Overview
Table 9.22 Sibelmed: Product Portfolio
Table 9.23 Sunrise: Company Overview
Table 9.24 Sunrise: Product Portfolio
Table 9.25 Vyaire Medical: Company Overview
Table 9.26 Vyaire Medical: Product Portfolio
Table 9.27 Wellue: Company Overview
Table 9.28 Wellue: Product Portfolio
Table 10.1 Sleep Apnea Therapeutic Device Developers: List of Companies (Detailed Profiles)
Table 10.2 Sleep Apnea Therapeutic Device Developers: List of Companies (Tabulated Profiles)
Table 10.3 Löwenstein Medical: Company Overview
Table 10.4 Söwenstein Medical: Device Portfolio
Table 10.5 ResMed: Company Overview
Table 10.6 ResMed: Device Portfolio
Table 10.7 ResMed: Recent Developments and Future Outlook
Table 10.8 SomnoMed: Company Overview
Table 10.9 SomnoMed: Device Portfolio
Table 10.10 SomnoMed: Recent Developments and Future Outlook
Table 10.11 Airway Management: Company Overview
Table 10.12 Airway Management: Device Portfolio
Table 10.13 Drive DeVilbiss Healthcare: Company Overview
Table 10.14 Drive DeVilbiss Healthcare: Device Portfolio
Table 10.15 Hunan VentMed Medical Technology: Company Overview
Table 10.16 Hunan VentMed Medical Technology: Device Portfolio
Table 10.17 Oventus: Company Overview
Table 10.18 Oventus: Device Portfolio
Table 10.19 Philips: Company Overview
Table 10.20 Philips: Device Portfolio
Table 10.21 React Health: Company Overview
Table 10.22 React Health: Device Portfolio
Table 10.23 Somnetics International: Company Overview
Table 10.24 Somnetics International: Device Portfolio
Table 10.25 Topson Medical: Company Overview
Table 10.26 Topson Medical: Device Portfolio
Table 10.27 Whole You: Company Overview
Table 10.28 Whole You: Device Portfolio
Table 11.1 Sleep Apnea Drug Therapy Developers: List of Companies (Detailed Profiles)
Table 11.2 Sleep Apnea Drug Therapy Developers: List of Companies Tabulated Profiles)
Table 11.3 Apnimed: Company Overview
Table 11.4 Apnimed: Drug Therapy Portfolio
Table 11.5 Apnimed: Recent Developments and Future Outlook
Table 11.6 Desitin Pharma: Company Overview
Table 11.7 Desitin Pharma: Drug Therapy Portfolio
Table 11.8 Desitin Pharma: Recent Developments and Future Outlook
Table 11.9 Incannex Healthcare: Company Overview
Table 11.10 Incannex Healthcare: Drug Therapy Portfolio
Table 11.11 Incannex Healthcare: Recent Developments and Future Outlook
Table 11.12 Bayer: Company Overview
Table 11.13 Bayer: Drug Therapy Portfolio
Table 11.14 Eli Lilly and Company: Company Overview
Table 11.15 Eli Lilly and Company: Drug Therapy Portfolio
Table 11.16 SciSparc: Company Overview
Table 11.17 SciSparc: Drug Therapy Portfolio
Table 13.1 Sleep Apnea Drug Therapies and Devices: List of Partnerships and Collaborations, 2017-2023
Table 14.1 Sleep Apnea: List of Funding and Investments, 2019-2023
Table 15.1 Patent Analysis: List of Top CPC Sections
Table 15.2 Patent Analysis: List of Top CPC Symbols
Table 15.3 Patent Analysis: List of Top CPC Codes
Table 15.4 Patent Analysis: Summary of Benchmarking Analysis
Table 15.5 Patent Analysis: Categorizations based on Relative Weighted Scores
Table 15.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 30.1 Sleep Apnea Diagnostic Devices: Distribution by Type of Device
Table 30.2 Sleep Apnea Diagnostic Devices: Distribution by Physiological Parameter Monitored
Table 30.3 Sleep Apnea Diagnostic Devices: Distribution by Type of Sleep Apnea Diagnosed
Table 30.4 Sleep Apnea Diagnostic Devices: Distribution by Device Connectivity
Table 30.5 Sleep Apnea Diagnostic Devices: Distribution by Target Patient Segment
Table 30.6 Sleep Apnea Diagnostic Devices: Distribution by End User
Table 30.7 Sleep Apnea Diagnostic Devices: Distribution by Price (USD)
Table 30.8 Sleep Apnea Diagnostic Device Developers: Distribution by Year of Establishment
Table 30.9 Sleep Apnea Diagnostic Device Developers: Distribution by Company Size
Table 30.10 Sleep Apnea Diagnostic Device Developers: Distribution by Location of Headquarters
Table 30.11 Sleep Apnea Diagnostic Device Developers: Distribution by Company Size and Location of Headquarters
Table 30.12 Sleep Apnea Therapeutic Devices: Distribution by Type of Sleep Apnea Treated
Table 30.13 Sleep Apnea Therapeutic Devices: Distribution by Therapeutic Principle
Table 30.14 Sleep Apnea Therapeutic Devices: Distribution by Type of Device
Table 30.15 Sleep Apnea Therapeutic Devices: Distribution by Type of Mask
Table 30.16 Sleep Apnea Therapeutic Devices: Distribution by Type of Treatment
Table 30.17 Sleep Apnea Therapeutic Devices: Distribution by Device Connectivity
Table 30.18 Sleep Apnea Therapeutic Devices: Distribution by Type of Storage Offered
Table 30.19 Sleep Apnea Therapeutic Devices: Distribution by Target Patient Segment
Table 30.20 Sleep Apnea Therapeutic Devices: Distribution by End User
Table 30.21 Sleep Apnea Therapeutic Devices: Distribution by Price
Table 30.22 Sleep Apnea Therapeutic Device Developers: Distribution by Year of Establishment
Table 30.23 Sleep Apnea Therapeutic Device Developers: Distribution by Company Size
Table 30.24 Sleep Apnea Therapeutic Device Developers: Distribution by Location of Headquarters
Table 30.25 Sleep Apnea Therapeutic Device Developers: Distribution by Company Size and Location of Headquarters
Table 30.26 Most Active Players: Distribution by Number of Products
Table 30.27 Sleep Apnea Drug Therapies: Distribution by Phase of Development
Table 30.28 Sleep Apnea Drug Therapies: Distribution by Type of Drug Therapy
Table 30.29 Sleep Apnea Drug Therapies: Distribution by Route of Administration
Table 30.30 Sleep Apnea Drug Therapies: Distribution by Number of Doses
Table 30.31 Sleep Apnea Drug Therapies: Distribution by Target Patient Segment
Table 30.32 Sleep Apnea Drug Therapy Developers (Industry Players): Distribution by Year of Establishment
Table 30.33 Sleep Apnea Drug Therapy Developers (Industry Players): Distribution by Company Size
Table 30.34 Sleep Apnea Drug Therapy Developers (Industry Players): Distribution by Location of Headquarters (Region)
Table 30.35 Sleep Apnea Drug Therapy Developers (Industry Players): Distribution by Company Size and Location of Headquarters
Table 30.36 Clinical Trial Analysis: Distribution by Trial Registration Year, 2019-2023
Table 30.37 Clinical Trial Analysis: Distribution by Trial Phase
Table 30.38 Clinical Trial Analysis: Distribution by Trial Status
Table 30.39 Clinical Trial Analysis: Distribution by Trial Registration Year and Trial Status
Table 30.40 Clinical Trial Analysis: Distribution by Type of Sponsor / Collaborator
Table 30.41 Clinical Trial Analysis: Distribution by Type of Patient Allocation Model Used
Table 30.42 Clinical Trial Analysis: Distribution by Type of Intervention
Table 30.43 Clinical Trial Analysis: Distribution by Type of Trial Masking Adopted
Table 30.44 Clinical Trial Analysis: Distribution by Trial Purpose
Table 30.45 Clinical Trial Analysis: Distribution by Trial Focus Area
Table 30.46 Clinical Trial Analysis: Distribution of Patients Enrolled by Trial Registration Year, 2019-2023
Table 30.47 Clinical Trial Analysis: Distribution of Patients Enrolled by Trial Phase
Table 30.48 Most Active Industry Players: Distribution by Number of Clinical Trials
Table 30.49 Most Active Non-Industry Players: Distribution by Number of Clinical Trials
Table 30.50 Clinical Trial Analysis: Distribution of Clinical Trials by Geography
Table 30.51 Clinical Trial Analysis: Distribution of Clinical Trials by Geography and Trial Status
Table 30.52 Clinical Trial Analysis: Distribution of Patients Enrolled by Trial Status and Geography
Table 30.53 Partnerships and Collaborations: Cumulative Year-Wise Trend, 2017-2023
Table 30.54 Partnerships and Collaborations: Distribution by Type of Partnership
Table 30.55 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 30.56 Partnerships and Collaborations: Distribution by Type of Partner
Table 30.57 Most Active Players: Distribution by Number of Partnerships
Table 30.58 Partnerships and Collaborations: Distribution by Local and International Agreements
Table 30.59 Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Deals
Table 30.60 Funding and Investment Analysis: Cumulative Distribution of Number of Instances by Year, 2019–2023
Table 30.61 Funding and Investment Analysis: Cumulative Distribution of Amount Invested by Year, 2019-2023 (USD Million)
Table 30.62 Funding and Investment Analysis: Distribution by Type of Funding
Table 30.63 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Table 30.64 Funding and Investment Analysis: Distribution of Amount Invested (USD Million) by Year and Type of Funding, 2019-2023
Table 30.65 Funding and Investment Analysis: Distribution by Investment Focus Area
Table 30.66 Most Active Players: Distribution by Number of Instances
Table 30.67 Most Active Players: Distribution by Amount Raised (USD Million)
Table 30.68 Funding and Investment Analysis: Distribution by Type of Investor
Table 30.69 Leading Investors: Distribution by Number of Instances
Table 30.70 Funding and Investment Analysis: Distribution of Number of Instances by Geography
Table 30.71 Funding and Investment Analysis: Distribution of Amount Invested by Geography (USD Million)
Table 30.72 Patent Analysis: Distribution by Type of Patent
Table 30.73 Patent Analysis: Cumulative Distribution by Patent Publication Year, 2019-2023
Table 30.74 Patent Analysis: Distribution by Type of Patent and Patent Publication Year
Table 30.75 Patent Analysis: Distribution by Patent Jurisdiction
Table 30.76 Patent Analysis: Distribution by Top CPC Sections
Table 30.77 Patent Analysis: Cumulative Distribution by Type of Applicant
Table 30.78 Leading Industry Players: Distribution by Number of Patents
Table 30.79 Leading Non-Industry Players: Distribution by Number of Patents
Table 30.80 Leading Individual Assignees: Distribution by Number of Patents
Table 30.81 Top CPC Codes: Benchmarking by Leading Industry Players
Table 30.82 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Table 30.83 Patent Analysis: Distribution by Patent Age
Table 30.84 Patent Analysis: Valuation Analysis
Table 30.85 Global Sleep Apnea Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.86 Global Sleep Apnea Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.87 Global Sleep Apnea Market: Distribution by Type of Product, 2018, 2023 and 2035 (USD Billion)
Table 30.88 Sleep Apnea Medical Devices: Historical Trends, 2018-2022 (USD Billion)
Table 30.89 Sleep Apnea Medical Devices: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.90 Drug Therapies: Forecasted Estimates, 2025-2035 (USD Billion)
Table 30.91 Sleep Apnea Diagnostic Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.92 Sleep Apnea Diagnostic Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.93 Sleep Apnea Diagnostic Devices Market: Distribution by Type of Diagnostic Device, 2018, 2023 and 2035 (USD Billion)
Table 30.94 Polysomnography Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.95 Polysomnography Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.96 Home Sleep Apnea Testing Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.97 Home Sleep Apnea Testing Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.98 Sleep Apnea Diagnostic Devices Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Billion)
Table 30.99 Sleep Apnea Diagnostic Devices Market in North America: Historical Trends, 2018-2022 (USD Billion)
Table 30.100 Sleep Apnea Diagnostic Devices Market in North America: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.101 Sleep Apnea Diagnostic Devices Market in Europe: Historical Trends, 2018-2022 (USD Billion)
Table 30.102 Sleep Apnea Diagnostic Devices Market in Europe: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.103 Sleep Apnea Diagnostic Devices Market in Asia-Pacific: Historical Trends, 2018-2022 (USD Billion)
Table 30.104 Sleep Apnea Diagnostic Devices Market in Asia-Pacific: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.105 Sleep Apnea Diagnostic Devices Market in Rest of the World: Historical Trends, 2018-2022 (USD Billion)
Table 30.106 Sleep Apnea Diagnostic Devices Market in Rest of the World: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.107 Sleep Apnea Therapeutic Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.108 Sleep Apnea Therapeutic Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.109 Sleep Apnea Therapeutic Devices Market: Distribution by Type of Therapeutic Device, 2018, 2023 and 2035 (USD Billion)
Table 30.110 PAP Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.111 PAP Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.112 Oral Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.113 Oral Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.114 Implanted Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.115 Implanted Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.116 Sleep Apnea Therapeutic Devices Market: Distribution by Type of PAP Device, 2018, 2023 and 2035 (USD Billion)
Table 30.117 CPAP Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.118 CPAP Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.119 BiPAP Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.120 BiPAP Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.121 APAP Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.122 APAP Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.123 Other Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.124 Other Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.125 Sleep Apnea Therapeutic Devices Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Billion)
Table 30.126 Sleep Apnea Therapeutic Devices Market in North America: Historical Trends, 2018-2022 (USD Billion)
Table 30.127 Sleep Apnea Therapeutic Devices Market in North America: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.128 Sleep Apnea Therapeutic Devices Market in Europe: Historical Trends, 2018-2022 (USD Billion)
Table 30.129 Sleep Apnea Therapeutic Devices Market in Europe: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.130 Sleep Apnea Therapeutic Devices Market in Asia-Pacific: Historical Trends, 2018-2022 (USD Billion)
Table 30.131 Sleep Apnea Therapeutic Devices Market in Asia-Pacific: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.132 Sleep Apnea Therapeutic Devices Market in Rest of the World: Historical Trends, 2018-2022 (USD Billion)
Table 30.133 Sleep Apnea Therapeutic Devices Market in Rest of the World: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.134 Sleep Apnea Drug Therapies Market: Forecasted Estimates, 2025-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 30.135 AD109: Sales Forecast, 2026-2035 (USD Million)
Table 30.136 Tirzepatide: Sales Forecast, 2025-2035 (USD Million)
Table 30.137 AD504: Sales Forecast, 2027-2035 (USD Million)
Table 30.138 IHL-42X: Sales Forecast, 2027-2035 (USD Million)
Table 30.139 DST-096 (Sulthiame): Sales Forecast, 2027-2035 (USD Million)
Table 30.140 AD182: Sales Forecast, 2026-2035 (USD Million)
Table 30.141 AD036, AD113, AD816: Sales Forecast, 2027-2035 (USD Million)
Table 30.142 Sleep Apnea Drug Therapies Market: Distribution by Route of Administration, 2025 and 2035
Table 30.143 Oral Drug Therapies Market: Forecasted Estimates, 2025-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 30.144 Subcutaneous Drug Therapies Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 30.145 Sleep Apnea Drug Therapies Market: Distribution by Key Geographical Regions, 2025 and 2035
Table 30.146 Sleep Apnea Drug Therapies Market in North America: Forecasted Estimates (2025-2035) (USD Million)
Table 30.147 Sleep Apnea Drug Therapies Market in the US: Forecasted Estimates (2025-2035) (USD Million)
Table 30.148 Sleep Apnea Drug Therapies Market in Mexico: Forecasted Estimates (2025-2035) (USD Million)
Table 30.149 Sleep Apnea Drug Therapies Market in Europe: Forecasted Estimates (2026-2035) (USD Million)
Table 30.150 Sleep Apnea Drug Therapies Market in Belgium: Forecasted Estimates (2027-2035) (USD Million)
Table 30.151 Sleep Apnea Drug Therapies Market in Germany: Forecasted Estimates (2026-2035) (USD Million)
Table 30.152 Sleep Apnea Drug Therapies Market in Asia-Pacific: Forecasted Estimates (2026-2035) (USD Million)
Table 30.153 Sleep Apnea Drug Therapies Market in Australia: Forecasted Estimates (2026-2035) (USD Million)
Table 30.154 Sleep Apnea Drug Therapies Market in China: Forecasted Estimates (2026-2035) (USD Million)
Table 30.155 Sleep Apnea Drug Therapies Market in Japan: Forecasted Estimates (2026-2035) (USD Million)
Table 30.156 Sleep Apnea Drug Therapies Market in Taiwan: Forecasted Estimates (2026-2035) (USD Million)
Table 30.157 Sleep Apnea Drug Therapies Market in Rest of the World (Brazil): Forecasted Estimates (2026-2035) (USD Million)